influenza
spread
around
world
season
epidem
result
death
hundr
thousand
peopl
pandem
year
sever
worldwid
influenza
outbreak
aros
last
centuri
claim
live
ten
million
pandem
caus
introduct
viral
strain
ha
subtyp
found
human
influenza
virus
novel
reassort
human
swine
influenza
virus
eurasian
avianlik
swine
mexico
follow
unit
state
nation
present
neuraminidas
na
inhibitor
oseltamivir
zanamivir
efficaci
current
strain
swine
origin
howev
viru
may
acquir
resist
avail
antivir
drug
fact
incid
rate
oseltamivirresist
influenza
virus
unit
state
increas
influenza
season
influenza
season
although
vaccin
also
avail
prevent
control
influenza
viru
infect
need
frequent
everi
year
case
season
influenza
accommod
mutat
ha
na
protein
circul
virus
antigen
drift
addit
recent
report
respons
variat
neutral
antibodi
pressur
individu
influenza
viru
evolv
adjust
receptor
bind
avid
via
amino
acid
substitut
throughout
ha
globular
domain
mani
simultan
alter
antigen
hostori
mechan
involv
influenza
infect
rather
viral
protein
therefor
envisag
promis
target
develop
novel
potent
therapeut
effect
irrespect
viral
subtyp
inde
sever
genomewid
screen
succeed
identifi
host
protein
particip
everi
step
influenza
viru
infect
includ
signal
molecul
relat
viral
replic
innat
immun
respons
apoptosi
well
signal
transduct
pathway
regul
fundament
physiolog
process
cell
prolifer
differenti
surviv
among
famili
lipid
kinas
kinas
key
regul
mani
cellular
process
one
commonli
list
host
factor
across
literatur
indic
crucial
role
protein
influenza
viru
infect
accordingli
report
multifunct
viral
nonstructur
protein
bind
directli
regulatori
subunit
stimul
lipid
kinas
activ
catalyt
subunit
although
activ
appar
import
promot
effici
viru
replic
late
step
infect
underli
mechan
contribut
viral
infect
remain
controversi
fact
paradox
report
inhibit
effect
initi
stage
infect
indic
bival
role
earli
late
stage
infect
pathway
influenza
transmiss
multistep
process
involv
adsorpt
viral
ha
sialyl
host
surfac
protein
entri
viru
cell
endocytosi
traffick
earli
late
endosom
virus
fuse
membran
late
endosom
releas
viral
gene
necessari
replic
grow
bodi
evid
show
influenza
virus
undergo
clathrindepend
endocytosi
howev
viru
still
enter
cell
even
inhibit
clathrin
caveolaemedi
endocytosi
suggest
influenza
virus
infect
cell
addit
clathrin
caveolaeindepend
endocyt
pathway
recent
report
bound
ra
preferenti
transloc
endosom
activ
subcellular
compart
howev
role
bind
endosom
yet
determin
studi
demonstr
signal
play
indispens
role
regul
clathrinindepend
endocytosi
influenza
viru
entri
order
test
whether
particip
regul
endocytosi
first
prepar
mous
embryon
fibroblast
mef
wildtyp
mice
mice
defici
gene
encod
catalyt
subunit
subtyp
clathrindepend
independ
endocytosi
cell
assess
uptak
fluoresc
label
transferrin
dextran
respect
treatment
wildtyp
mef
inhibitor
significantli
reduc
uptak
dextran
transferrin
figur
b
confirm
specif
involv
clathrinindepend
endocytosi
report
previous
mef
also
display
inhibitori
effect
dextran
uptak
howev
inhibitori
effect
observ
mutant
mef
significantli
less
cell
figur
p
vs
express
mutant
cell
differ
capac
dextran
uptak
wildtyp
mef
could
account
remain
activ
subtyp
cell
interestingli
mutant
fail
bind
ra
henc
transloc
endosom
via
activ
ra
figur
b
unabl
display
compensatori
effect
unlik
wildtyp
counterpart
figur
express
level
shown
compar
immunoblot
figur
given
mutant
lack
rasbind
retain
catalyt
activ
result
demonstr
signific
rasmedi
activ
regul
clathrinindepend
endocytosi
pathway
also
particip
endosom
matur
simultan
visual
earli
endosom
late
endosomeslysosom
fluoresc
label
dextran
lysotrack
respect
reveal
dextran
transfer
late
endosom
significantli
delay
cell
activ
bind
absent
figur
lane
figur
consist
find
cellular
event
relat
endosom
matur
specif
disturb
cell
lack
interact
efficaci
transfect
lipidconjug
plasmid
dna
thought
transmit
cell
via
fluid
phase
clathrinindepend
endocytosi
significantli
impair
mef
impair
rescu
express
wildtyp
express
mutant
figur
contrast
gene
transfer
electropor
affect
test
condit
figur
indic
endocytosismedi
event
protein
express
specif
disrupt
mef
fact
endosom
matur
activ
implic
influenza
viru
infect
especi
earli
stage
encourag
us
examin
statu
influenza
viru
infect
system
expect
challeng
apuerto
strain
result
reduc
titer
progeni
virus
cell
assess
convent
plaqu
assay
figur
resist
influenza
restor
express
wildtyp
mutant
figur
similar
infect
profil
obtain
aichi
virus
use
figur
therefor
state
suppress
interact
effect
manner
independ
influenza
subtyp
test
whether
intern
intracellular
traffick
infect
viral
particl
regul
interact
prepar
aforement
cell
line
express
marker
earli
late
endosom
respect
immunofluoresc
analysi
use
antibodi
influenza
nucleoprotein
np
reveal
total
number
adsorb
viru
particl
compar
among
test
condit
figur
howev
ratio
particl
coloc
rab
protein
total
number
particl
expect
repres
viru
entri
rate
reduc
wildtyp
mef
mef
knockout
mef
express
mutant
figur
figur
c
find
consist
result
dextran
uptak
see
figur
deliveri
viral
particl
earli
late
endosom
analyz
calcul
ratio
viru
particl
coloc
total
number
intern
particl
concomitantli
retard
knockout
cell
mutant
cell
figur
suggest
signal
also
modul
viru
traffick
earli
late
endosom
via
regul
endosom
matur
see
figur
inhibitor
promot
retent
earli
endosom
effici
ablat
figur
p
indic
subtyp
also
play
role
viral
traffick
influenza
virus
may
also
exploit
signal
pathway
expedit
incorpor
cell
creat
favor
condit
shown
figur
dextran
uptak
significantli
increas
upon
infect
wildtyp
mef
mef
express
wildtyp
contrast
inhibitortr
wildtyp
mef
knockout
mef
knockout
mef
express
mutant
display
similar
lower
basal
incorpor
activ
margin
upregul
viral
infect
figur
therebi
highlight
signal
critic
hostori
mechan
incorpor
influenza
virus
next
examin
whether
influenza
infect
fact
activ
signal
examin
activ
endogen
ra
use
bo
pulldown
method
gtpbound
activ
ra
recov
cell
lysat
preferenti
avid
gstfuse
rasbind
domain
rbd
shown
figur
b
ra
activ
effici
promot
minut
infect
irrespect
presenc
absenc
ra
activ
could
also
observ
cell
figur
addit
express
domin
neg
mutant
ra
ra
inhibit
influenza
viru
infect
wherea
express
wildtyp
counterpart
rather
enhanc
infect
figur
e
togeth
demonstr
requir
ra
influenza
viru
infect
assess
phosphoryl
statu
akt
commonli
use
marker
activ
immunoblot
use
antibodi
specif
phosphoryl
akt
pakt
surprisingli
although
influenza
infect
definit
inhibit
cell
akt
phosphoryl
induc
viru
exposur
hour
figur
upon
pdgf
stimul
essenti
similar
ra
akt
activ
observ
even
absenc
figur
consist
previou
report
akt
phosphoryl
level
induc
extracellular
stimuli
alter
ablat
moreov
although
bind
ra
critic
influenza
viru
infect
see
figur
b
kinet
akt
phosphoryl
appar
distinct
ra
activ
figur
fact
kinet
akt
phosphoryl
induc
influenza
viru
infect
report
manner
depend
cell
context
viral
strain
therefor
postul
activ
disturb
manner
specif
subcellular
local
system
akt
phosphoryl
wholecel
level
inappropri
indic
activ
earli
stage
infect
gfptag
pleckstrin
homolog
ph
domain
akt
phgfp
therefor
util
monitor
activ
aktph
recogn
product
phosphatidylinositol
trisphosph
hydrolyt
product
pi
therefor
molecul
tag
fluoresc
protein
give
measur
activ
spatiotempor
precis
transloc
specif
subcellular
organel
domin
neg
effect
express
protein
influenza
infect
report
care
identifi
express
level
phgfp
would
avoid
inhibit
infect
figur
b
condit
accumul
phgfp
reflect
activ
promot
influenza
viru
infect
could
observ
plasma
membran
also
vesicular
structur
influenza
viru
particl
coloc
figur
given
express
ra
well
treatment
inhibit
coloc
say
accumul
earli
endosom
requir
ra
addit
activ
per
se
interestingli
wherea
viru
particl
could
local
earli
posit
late
posit
endosom
fluoresc
proteintag
ph
domain
could
earli
endosom
figur
b
find
suggest
also
requir
transit
earli
endosom
late
endosom
activ
alreadi
diminish
inhibit
activ
actual
result
retent
viral
particl
earli
endosom
see
figur
furthermor
upon
viral
infect
ra
coloc
viral
particl
ph
domain
manner
depend
ra
activ
figur
given
ra
indispens
activ
endosom
result
togeth
underscor
import
role
pathway
product
earli
endosom
upon
viral
infect
pathway
gain
gener
accept
one
key
regul
cellular
entri
rang
virus
intracellular
bacteria
howev
mechanist
scenario
function
far
understood
herebi
show
rasmedi
activ
mainli
requir
viru
entri
infect
consist
report
inhibit
effect
reduc
titer
progeni
virus
inhibitor
appli
earlier
hpi
wherea
treatment
hpi
later
abl
display
effect
anymor
given
lack
bind
fail
local
endosom
figur
b
ra
play
determin
role
virusinduc
transient
activ
endosom
notwithstand
activ
phosphoryl
major
downstream
molecul
akt
earli
stage
signific
becam
promin
postentri
stage
figur
kinet
akt
phosphoryl
consist
previou
report
transient
akt
phosphoryl
detect
lesser
amplitud
observ
late
stage
manner
specif
cell
context
viral
strain
observ
regard
small
amplitud
akt
phosphoryl
may
account
restrict
activ
earli
endosom
present
proport
akt
activ
total
akt
determin
extent
phosphoryl
akt
detect
immunoblot
altern
given
express
wildtyp
dominantneg
form
akt
significantli
alter
viru
entri
endosom
may
util
bind
factor
akt
regul
viru
entri
hand
find
rule
implic
signal
late
event
infect
replic
fact
promin
akt
phosphoryl
observ
hpi
immunoblot
figur
b
report
previous
time
cours
akt
activ
appar
differ
ra
activ
slow
akt
activ
may
independ
ra
rather
mediat
viral
protein
direct
bind
regulatori
subunit
pathway
also
report
particip
event
associ
late
step
includ
regul
interferon
product
interferon
regulatori
factor
irf
phosphoryl
respons
doublestrand
rna
influenza
virus
upregul
signal
earli
stage
effici
entri
remain
obscur
first
step
influenza
viru
infect
adsorpt
sialyl
protein
cell
surfac
thu
type
sialyl
cell
surfac
protein
great
import
determin
viru
host
specif
howev
none
sialyl
protein
identifi
singl
specif
receptor
viru
date
hand
recent
report
mannos
receptor
sialic
acidindepend
receptor
influenza
virus
macrophag
given
strain
use
studi
capabl
activ
ra
bind
macrophag
cell
surfac
molecul
includ
receptor
sialidas
treatment
signal
transduc
influenza
viru
ra
sialyl
protein
regard
noteworthi
receptor
tyrosin
kinas
fibroblast
growth
factor
receptor
list
host
factor
implic
influenza
viru
infect
sever
genomewid
studi
howev
acceptor
mechan
like
domin
preliminari
experi
show
receptor
inhibitor
produc
margin
effect
infect
level
phosphoryl
tyrosin
total
cell
lysat
strikingli
alter
infect
data
shown
present
studi
util
class
ib
express
manner
independ
regulatori
subunit
allow
complementari
express
catalyt
subunit
cell
demonstr
one
may
rais
concern
use
fibroblast
model
express
pattern
molecul
thought
restrict
within
leukocyt
howev
recent
accumul
evid
indic
function
express
much
wider
rang
cell
context
previous
believ
eg
endotheli
cell
cardiomyocyt
cardiofibroblast
vast
major
solid
cancer
cell
present
studi
genet
ablat
fibroblast
inde
result
decreas
endocyt
abil
influenza
infect
figur
moreov
similar
inhibitori
effect
phenomena
also
observ
inhibitor
sever
cell
line
test
data
shown
prove
appar
indispens
oper
influenza
viru
entri
varieti
cell
line
includ
fibroblast
subtyp
includ
class
ia
may
also
particip
influenza
viru
infect
inhibitor
achiev
effici
inhibit
pharmacolog
genet
inhibit
among
stage
influenza
life
cycl
viral
entri
one
remain
sanctuari
target
prevent
therapi
addit
viru
intern
adsorpt
rel
nonspecif
process
conserv
rang
viral
subtyp
speci
therefor
present
promis
target
achiev
potent
therapeut
broad
spectrum
efficaci
lower
rate
resist
end
number
studi
attempt
identifi
mechan
influenza
enter
cell
implic
clathrinmedi
endocytosi
viru
particl
inde
intern
howev
express
dominantneg
form
knockdown
epsin
involv
clathrinmedi
endocytosi
hamper
influenza
viru
infect
contrast
ablat
interact
restrain
influenza
viru
intern
via
inhibit
clathrinindepend
endocytosi
figur
underscor
clathrinindepend
endocytosi
one
key
pathway
influenza
viru
entri
wherea
clathrindepend
endocytosi
support
one
find
may
also
appli
virus
apart
influenza
virus
name
sever
acut
respiratori
syndrom
sar
coronaviru
dengu
viru
known
infect
via
clathrinindepend
endocytosi
summari
interact
identifi
hostori
mechan
influenza
intern
implic
specif
cellular
phenomena
includ
clathrinindepend
endocytosi
endosom
matur
separ
clathrindepend
endocytosi
necessari
number
import
biolog
event
receptor
downregul
lowdens
lipoprotein
incorpor
fact
adult
mice
defici
ra
bind
healthi
inhibit
signal
pathway
could
lead
develop
use
welltoler
prevent
strategi
varieti
viral
infect
would
aid
develop
effect
countermeasur
viral
pandem
cdna
obtain
l
stephen
babraham
institut
uk
pcrmediat
mutagenesi
perform
obtain
cdna
encod
mutant
harbor
mutat
within
rbd
abrog
interact
ra
result
pcr
product
subclon
xhoinoti
site
express
vector
kindli
provid
tsuboi
univers
tokyo
tokyo
japan
hatag
wildtyp
cfptag
aktph
describ
previous
cdna
amplifi
pcr
subclon
xhoinoti
site
pcaggsecfp
pcaggsvenu
vector
respect
express
plasmid
wild
type
wt
domin
neg
mutant
ra
kindli
provid
matsuda
kyoto
univers
kyoto
japan
note
vector
design
ra
express
monitor
fluoresc
bicistron
express
gfp
rfp
mous
embryon
fibroblast
mef
defici
prepar
describ
maintain
dmem
sigma
st
loui
mo
supplement
fb
humidifi
atmospher
contain
express
vector
wildtyp
mutant
linear
scai
introduc
cell
use
nucleofect
accord
manufactur
recommend
amaxa
biosystem
cologn
germani
start
day
cell
cultur
dmem
contain
mgml
sulfat
sigma
resist
coloni
collect
isol
express
protein
confirm
immunoblot
see
figur
stabli
transfect
cell
maintain
dmem
supplement
mgml
human
embryon
kidney
cell
obtain
american
type
cultur
collect
manassa
va
japanes
collect
research
bioresourc
cell
bank
respect
maintain
dmem
supplement
fb
mdck
cell
maintain
mem
supplement
fb
transfect
express
plasmid
introduc
fugen
hd
roch
basel
switzerland
accord
manufactur
recommend
dextran
mr
transferrin
lysotrack
red
antimous
antibodi
antirat
antimous
antibodi
purchas
invitrogen
carlsbad
ca
obtain
calbiochem
san
diego
ca
antibodi
purchas
bd
bioscienc
san
jose
ca
ha
roch
ra
oncogen
research
product
cambridg
santa
cruz
biotechnolog
santa
cruz
ca
phosphoakt
akt
cell
signal
technolog
danver
antinp
antibodi
kind
gift
takada
hokkaido
univers
sapporo
japan
influenza
viru
strain
apuerto
aichi
propag
chorioallanto
caviti
embryon
hen
egg
hour
infect
mef
wash
pb
infect
aichi
multipl
infect
moi
hour
inoculum
aspir
cell
incub
dmem
day
amount
infecti
viru
cell
supernat
determin
use
common
plaqu
assay
describ
previous
briefli
confluent
monolay
mdck
cell
plate
inocul
supernat
hour
adsorpt
cell
supernat
remov
cell
overlaid
mem
contain
bactagar
trypsin
plaqu
enumer
incub
day
cell
fix
paraformaldehyd
minut
rt
permeabil
triton
pb
minut
rt
incub
bovin
serum
albumin
block
nonspecif
bind
antibodi
cell
incub
primari
antibodi
overnight
follow
secondari
antibodi
dilut
molecular
probe
invitrogen
hour
rt
dark
imag
acquir
use
confoc
microscop
olympu
tokyo
japan
assess
endocytosi
cell
plate
collagenco
mm
diamet
glass
base
dish
asahi
techno
glass
co
tokyo
japan
incub
fluorescenceconjug
dextran
transferrin
minut
wash
extens
pb
transfer
phenol
redfre
invitrogen
cell
imag
use
olympu
microscop
equip
coolsnap
hq
cool
chargecoupl
devic
photometr
tucson
az
visual
vesicl
extract
use
top
hat
function
metamorph
imag
process
softwar
univers
imag
downingtown
pa
follow
quantif
fluoresc
intens
analysi
endosom
matur
cell
simultan
label
nm
lysotrack
red
minut
wash
pb
cell
incub
lysotrack
red
follow
quantif
describ
cell
lyse
ripa
buffer
mm
ph
mm
nacl
mm
edta
sd
sodium
deoxychol
mm
minut
ice
lysat
clarifi
centrifug
supernat
subject
separ
protein
blot
polyvinyliden
difluorid
membran
biorad
hercul
ca
signal
develop
ecl
western
blot
detect
reagent
ge
healthcar
littl
chalfont
uk
detect
use
mini
imag
analyz
fujifilm
tokyo
japan
escherichia
coli
express
vector
gstfuse
rbd
pgexrafrbd
obtain
hattori
kitasato
univers
tokyo
japan
detect
gtpbound
ra
perform
essenti
describ
previous
slight
modif
briefli
cell
lyse
lysi
buffer
mm
ph
mm
nacl
mm
sodium
deoxychol
sd
mm
clarifi
centrifug
incub
gstrafrbd
minut
result
complex
gtpbound
ra
gstrafrbd
precipit
bead
wash
twice
lysi
buffer
elut
gtpbound
ra
detect
immunoblot
data
unless
otherwis
specifi
express
box
whisker
plot
highest
lowest
boundari
box
repres
percentil
respect
whisker
box
design
percentil
respect
line
within
box
indic
median
valu
altern
data
display
figur
mean
sd
three
independ
experi
perform
triplic
data
subject
oneway
analysi
varianc
follow
comparison
use
student
ttest
evalu
differ
p
valu
obtain
test
found
figur
legend
